Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer
- 29 December 2015
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 23 (5), 1569-1575
- https://doi.org/10.1245/s10434-015-5028-8
Abstract
Emerging evidence suggests that metformin decreases the risk of developing colorectal cancer in patients with diabetes, but only few studies have examinedKeywords
Funding Information
- Arvid Nilssons Fond
This publication has 20 references indexed in Scilit:
- Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-AnalysisPLOS ONE, 2014
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studiesBMJ, 2014
- Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2013
- Metformin: Multi-faceted protection against cancerOncotarget, 2011
- Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studiesEuropean Journal of Epidemiology, 2011
- Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences, 2009
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes MellitusJAMA, 2008
- Multimorbidity and Survival in Older Persons with Colorectal CancerJournal of the American Geriatrics Society, 2006
- Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2005
- Impact of Diabetes Mellitus on Outcomes in Patients With Colon CancerJournal of Clinical Oncology, 2003